Pancreatic Cancer Research

ResearcherSeoul National UniversityNo recent work listed

Nayoung Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9397-0406; OpenAlex author ID A5100348065. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 4

  1. Incidence and risk of pancreatic cancer in patients with acute or chronic pancreatitis: a population-based cohort study. Co-author DOI 10.1038/s41598-023-45382-y↗
  2. Incidence and Mortality Rates of Second Pancreatic Cancer Among Survivors of Digestive Cancers: A Nationwide Population-Based Study. Co-author DOI 10.1097/mpa.0000000000001254↗
  3. Accuracy of an administrative database for pancreatic cancer by international classification of disease 10th codes: A retrospective large-cohort study. Last author DOI 10.3748/wjg.v25.i37.5619↗
  4. Fisetin Enhances the Cytotoxicity of Gemcitabine by Down-regulating ERK-MYC in MiaPaca-2 Human Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.12624↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Seon Mee Park · 3 shared papers, 2019–2023 · strength 0.43
  2. Hyun Jung Kim Kim · 1 shared paper, 2023 · strength 0.20
  3. Jong-Chan Lee · 1 shared paper, 2019 · strength 0.11
  4. Soomin Ahn · 1 shared paper, 2019 · strength 0.11
  5. Young‐Jae Hwang · 1 shared paper, 2019 · strength 0.11
  6. Hyeong Sik Ahn · 1 shared paper, 2019 · strength 0.11
  7. Hyun Jung Kim · 1 shared paper, 2019 · strength 0.11
  8. Yong-Tae Kim · 1 shared paper, 2018 · strength 0.09
  9. Woo Hyun Paik · 1 shared paper, 2018 · strength 0.09
  10. Sang Hyub Lee · 1 shared paper, 2018 · strength 0.09
  11. Ji Kon Ryu · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.